These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25225425)

  • 21. Male pattern baldness and risk of incident skin cancer in a cohort of men.
    Li WQ; Cho E; Han J; Weinstock MA; Qureshi AA
    Int J Cancer; 2016 Dec; 139(12):2671-2678. PubMed ID: 27542665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between male pattern baldness and prostate disease: A meta-analysis.
    Jin T; Wu T; Luo Z; Duan X; Deng S; Tang Y
    Urol Oncol; 2018 Feb; 36(2):80.e7-80.e15. PubMed ID: 29054497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
    Giles GG; Severi G; Sinclair R; English DR; McCredie MR; Johnson W; Boyle P; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):549-53. PubMed ID: 12050096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent associations between androgenetic alopecia and prostate cancer risk.
    Muller DC; Giles GG; Sinclair R; Hopper JL; English DR; Severi G
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):209-15. PubMed ID: 23074289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study.
    Downer MK; Kenfield SA; Stampfer MJ; Wilson KM; Dickerman BA; Giovannucci EL; Rimm EB; Wang M; Mucci LA; Willett WC; Chan JM; Van Blarigan EL
    J Clin Oncol; 2019 Jun; 37(17):1499-1511. PubMed ID: 31026211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Male pattern baldness and the risk of prostate cancer.
    Yassa M; Saliou M; De Rycke Y; Hemery C; Henni M; Bachaud JM; Thiounn N; Cosset JM; Giraud P
    Ann Oncol; 2011 Aug; 22(8):1824-7. PubMed ID: 21324955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials.
    O'Grady TJ; Kitahara CM; DiRienzo AG; Boscoe FP; Gates MA
    PLoS One; 2014; 9(9):e106880. PubMed ID: 25192282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Male pattern baldness and incidence of prostate cancer: A systematic review and meta-analysis.
    He H; Xie B; Xie L
    Medicine (Baltimore); 2018 Jul; 97(28):e11379. PubMed ID: 29995779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer.
    Murtola TJ; Kasurinen TVJ; Talala K; Taari K; Tammela TLJ; Auvinen A
    Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):66-76. PubMed ID: 30214034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Kitahara CM; Berndt SI; de González AB; Coleman HG; Schoen RE; Hayes RB; Huang WY
    J Clin Oncol; 2013 Jul; 31(19):2450-9. PubMed ID: 23715565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study.
    Siddiqui MM; Wilson KM; Epstein MM; Rider JR; Martin NE; Stampfer MJ; Giovannucci EL; Mucci LA
    J Clin Oncol; 2014 Sep; 32(27):3033-8. PubMed ID: 25002716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up.
    Shafique K; McLoone P; Qureshi K; Leung H; Hart C; Morrison DS
    BMC Cancer; 2012 Jan; 12():25. PubMed ID: 22260413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation of Prostate-specific Antigen Value in Men and Risk of High-grade Prostate Cancer: Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study.
    Boniol M; Autier P; Perrin P; Boyle P
    Urology; 2015 May; 85(5):1117-1122. PubMed ID: 25917734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.
    Ahearn TU; Pettersson A; Ebot EM; Gerke T; Graff RE; Morais CL; Hicks JL; Wilson KM; Rider JR; Sesso HD; Fiorentino M; Flavin R; Finn S; Giovannucci EL; Loda M; Stampfer MJ; De Marzo AM; Mucci LA; Lotan TL
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26615022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?
    Liang Y; Ketchum NS; Goodman PJ; Klein EA; Thompson IM
    J Urol; 2014 Oct; 192(4):1094-9. PubMed ID: 24747090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer mortality in the Finnish randomized screening trial.
    Kilpeläinen TP; Tammela TL; Malila N; Hakama M; Santti H; Määttänen L; Stenman UH; Kujala P; Auvinen A
    J Natl Cancer Inst; 2013 May; 105(10):719-25. PubMed ID: 23479454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatherhood status in relation to prostate cancer risks in two large U.S.-based prospective cohort studies.
    Geczik AM; Kelly SP; Pfeiffer RM; Huang WY; Liao LM; Zhou CK; Brinton LA; Cook MB
    Cancer Med; 2021 Jan; 10(1):405-415. PubMed ID: 33219755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).
    Randazzo M; Müller A; Carlsson S; Eberli D; Huber A; Grobholz R; Manka L; Mortezavi A; Sulser T; Recker F; Kwiatkowski M
    BJU Int; 2016 Apr; 117(4):576-83. PubMed ID: 26332304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.
    Kirsh VA; Hayes RB; Mayne ST; Chatterjee N; Subar AF; Dixon LB; Albanes D; Andriole GL; Urban DA; Peters U;
    J Natl Cancer Inst; 2006 Feb; 98(4):245-54. PubMed ID: 16478743
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.